Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,810.00
+100.00 (1.49%)
Last updated: Jul 17, 2025
-10.63%
Market Cap77.70B
Revenue (ttm)85.92B
Net Income (ttm)12.65B
Shares Out11.38M
EPS (ttm)1,094.66
PE Ratio6.24
Forward PEn/a
Dividend190.00 (2.78%)
Ex-Dividend DateDec 27, 2024
Volume33,073
Average Volume41,259
Open6,760.00
Previous Close6,710.00
Day's Range6,680.00 - 6,850.00
52-Week Range5,920.00 - 8,320.00
Beta1.42
RSI56.31
Earnings DateAug 12, 2025

About Sinil Pharmaceutical

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In ... [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 287
Stock Exchange KOSDAQ
Ticker Symbol 012790
Full Company Profile

Financial Performance

In 2024, Sinil Pharmaceutical's revenue was 89.44 billion, an increase of 0.34% compared to the previous year's 89.14 billion. Earnings were 14.30 billion, an increase of 4.83%.

Financial Statements

News

There is no news available yet.